Jon M. Foster - 15 May 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and COO
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 15 May 2024
Net transactions value: -$3,519,394
Form type: 4
Filing time: 18 Nov 2024, 17:47:55 UTC
Previous filing: 21 Feb 2024
Next filing: 30 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Gift	$0	-5,350	-100%	$0.000000	0	15 May 2024	By Spouse
transaction	HCA	Common Stock	Gift	$0	+5,350	+11%	$0.000000	54,308	15 May 2024	By LCF Trust (Reporting Person, Trustee)
transaction	HCA	Common Stock	Other	$3,351,735	-9,502	-24%	$352.74	30,535	14 Nov 2024	Direct	F1
transaction	HCA	Common Stock	Other	$3,351,735	+9,502	+17%	$352.74	64,560	14 Nov 2024	By JMF Trust (Spouse and Robert Nagel, Co-Trustees)	F1
transaction	HCA	Common Stock	Gift	$0	-1,955	-6.4%	$0.000000	28,580	14 Nov 2024	Direct
transaction	HCA	Common Stock	Gift	$0	+1,955	+3%	$0.000000	66,515	14 Nov 2024	By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
transaction	HCA	Common Stock	Gift	$0	-18,000	-63%	$0.000000	10,580	14 Nov 2024	Direct
transaction	HCA	Common Stock	Gift	$0	+18,000		$0.000000	18,000	14 Nov 2024	By Spouse
transaction	HCA	Common Stock	Options Exercise	$3,702,456	+36,600	+346%	$101.16	47,180	14 Nov 2024	Direct
transaction	HCA	Common Stock	Tax liability	$7,221,850	-20,902	-44%	$345.51	26,278	14 Nov 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCA	Stock Appreciation Right	Options Exercise	$0	-36,600	-100%	$0.000000	0	14 Nov 2024	Common Stock	36,600	$101.16	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to a power of substitution, on November 14, 2024, the Reporting Person transferred 9,502 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $352.74 (the average of the high and low prices of shares of common stock of the Issuer on November 14, 2024). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership.
F2	The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

Content

Pursuant to a power of substitution, on November 14, 2024, the Reporting Person transferred 9,502 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $352.74 (the average of the high and low prices of shares of common stock of the Issuer on November 14, 2024). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership.

The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.